Is DaVita HealthCare Stock a Good Investment?
DaVita HealthCare Investment Advice | DVA |
- Examine DaVita HealthCare's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research DaVita HealthCare's leadership team and their track record. Good management can help DaVita HealthCare navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact DaVita HealthCare's business and its evolving consumer preferences.
- Compare DaVita HealthCare's performance and market position to its competitors. Analyze how DaVita HealthCare is positioned in terms of product offerings, innovation, and market share.
- Check if DaVita HealthCare pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about DaVita HealthCare's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in DaVita HealthCare Partners stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if DaVita HealthCare Partners is a good investment.
Sell | Buy |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine DaVita HealthCare Stock
Researching DaVita HealthCare's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 50.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.11. DaVita HealthCare recorded earning per share (EPS) of 10.74. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 9th of September 2013.
To determine if DaVita HealthCare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding DaVita HealthCare's research are outlined below:
| DaVita HealthCare generated a negative expected return over the last 90 days | |
| About 50.0% of the company shares are held by company insiders | |
| Latest headline from kalkinemedia.com: Why Is DaVita Inc. Gaining Attention in the Healthcare Sector |
DaVita HealthCare Quarterly Good Will |
|
DaVita HealthCare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in DaVita HealthCare Partners. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to DaVita HealthCare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact DaVita HealthCare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises DaVita HealthCare's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2002-02-26 | 2001-12-31 | 0.1 | 0.11 | 0.01 | 10 | ||
2001-11-05 | 2001-09-30 | 0.09 | 0.1 | 0.01 | 11 | ||
2001-08-02 | 2001-06-30 | 0.08 | 0.09 | 0.01 | 12 | ||
2001-05-18 | 2001-03-31 | 0.07 | 0.08 | 0.01 | 14 | ||
2000-11-09 | 2000-09-30 | 0.04 | 0.05 | 0.01 | 25 | ||
2000-05-11 | 2000-03-31 | 0.01 | 0.02 | 0.01 | 100 | ||
2000-03-23 | 1999-12-31 | 0.01 | 0.02 | 0.01 | 100 | ||
1999-11-10 | 1999-09-30 | 0.06 | 0.05 | -0.01 | 16 |
DaVita HealthCare Target Price Consensus
DaVita target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. DaVita HealthCare's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 10 | Buy |
Most DaVita analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand DaVita stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of DaVita HealthCare, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationDaVita HealthCare Target Price Projection
DaVita HealthCare's current and average target prices are 142.98 and 161.59, respectively. The current price of DaVita HealthCare is the price at which DaVita HealthCare Partners is currently trading. On the other hand, DaVita HealthCare's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
DaVita HealthCare Market Quote on 25th of February 2025
Target Price
Analyst Consensus On DaVita HealthCare Target Price
DaVita HealthCare Analyst Ratings
DaVita HealthCare's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about DaVita HealthCare stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of DaVita HealthCare's financials, market performance, and future outlook by experienced professionals. DaVita HealthCare's historical ratings below, therefore, can serve as a valuable tool for investors.Know DaVita HealthCare's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as DaVita HealthCare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading DaVita HealthCare Partners backward and forwards among themselves. DaVita HealthCare's institutional investor refers to the entity that pools money to purchase DaVita HealthCare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Northern Trust Corp | 2024-12-31 | 740.8 K | Gates Capital Management Inc | 2024-12-31 | 717.5 K | Allianz Asset Management Ag | 2024-12-31 | 534.1 K | Charles Schwab Investment Management Inc | 2024-12-31 | 489.3 K | Ubs Asset Mgmt Americas Inc | 2024-12-31 | 466 K | Amundi | 2024-12-31 | 446.4 K | Citadel Advisors Llc | 2024-09-30 | 433.8 K | Deutsche Bank Ag | 2024-12-31 | 392.4 K | Bank Of New York Mellon Corp | 2024-12-31 | 381.8 K | Berkshire Hathaway Inc | 2024-12-31 | 36.1 M | Vanguard Group Inc | 2024-12-31 | 5.2 M |
DaVita HealthCare's market capitalization trends
The company currently falls under 'Large-Cap' category with a total capitalization of 11.36 B.Market Cap |
|
DaVita HealthCare's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.10 | 0.07 | |
| Return On Capital Employed | 0.15 | 0.15 | |
| Return On Assets | 0.05 | 0.04 | |
| Return On Equity | 7.73 | 8.12 |
Determining DaVita HealthCare's profitability involves analyzing its financial statements and using various financial metrics to determine if DaVita HealthCare is a good buy. For example, gross profit margin measures DaVita HealthCare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of DaVita HealthCare's profitability and make more informed investment decisions.
Please note, the presentation of DaVita HealthCare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, DaVita HealthCare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of DaVita HealthCare's management manipulating its earnings.
Evaluate DaVita HealthCare's management efficiency
DaVita HealthCare has Return on Asset of 0.0715 % which means that on every $100 spent on assets, it made $0.0715 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.5174 %, implying that it generated $0.5174 on every 100 dollars invested. DaVita HealthCare's management efficiency ratios could be used to measure how well DaVita HealthCare manages its routine affairs as well as how well it operates its assets and liabilities. At present, DaVita HealthCare's Return On Capital Employed is projected to slightly decrease based on the last few years of reporting. The current year's Return On Equity is expected to grow to 8.12, whereas Return On Tangible Assets are forecasted to decline to 0.07. At present, DaVita HealthCare's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 247.1 M, whereas Total Assets are forecasted to decline to about 10.5 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 24.61 | 25.84 | |
| Tangible Book Value Per Share | (64.49) | (61.27) | |
| Enterprise Value Over EBITDA | 8.55 | 10.84 | |
| Price Book Value Ratio | 104.94 | 110.19 | |
| Enterprise Value Multiple | 8.55 | 10.84 | |
| Price Fair Value | 104.94 | 110.19 | |
| Enterprise Value | 19.4 B | 20.4 B |
The leadership approach at DaVita HealthCare's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Beta 0.934 |
Basic technical analysis of DaVita Stock
As of the 25th of February, DaVita HealthCare shows the Market Risk Adjusted Performance of (0.12), mean deviation of 1.36, and Standard Deviation of 2.11. DaVita HealthCare technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.DaVita HealthCare's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DaVita HealthCare insiders, such as employees or executives, is commonly permitted as long as it does not rely on DaVita HealthCare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases DaVita HealthCare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
DaVita HealthCare's Outstanding Corporate Bonds
DaVita HealthCare issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. DaVita HealthCare uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most DaVita bonds can be classified according to their maturity, which is the date when DaVita HealthCare Partners has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| DAVITA INC 375 Corp BondUS23918KAT51 | View | |
| DaVita 4625 percent Corp BondUS23918KAS78 | View |
Understand DaVita HealthCare's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing DaVita HealthCare's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.12) | |||
| Mean Deviation | 1.36 | |||
| Coefficient Of Variation | (1,310) | |||
| Standard Deviation | 2.11 | |||
| Variance | 4.43 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.16) | |||
| Treynor Ratio | (0.13) | |||
| Maximum Drawdown | 14.24 | |||
| Value At Risk | (2.71) | |||
| Potential Upside | 2.92 | |||
| Skewness | (2.30) | |||
| Kurtosis | 10.73 |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.12) | |||
| Mean Deviation | 1.36 | |||
| Coefficient Of Variation | (1,310) | |||
| Standard Deviation | 2.11 | |||
| Variance | 4.43 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.16) | |||
| Treynor Ratio | (0.13) | |||
| Maximum Drawdown | 14.24 | |||
| Value At Risk | (2.71) | |||
| Potential Upside | 2.92 | |||
| Skewness | (2.30) | |||
| Kurtosis | 10.73 |
Consider DaVita HealthCare's intraday indicators
DaVita HealthCare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of DaVita HealthCare stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 27110.06 | |||
| Daily Balance Of Power | 0.2901 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 142.18 | |||
| Day Typical Price | 142.45 | |||
| Price Action Indicator | 1.27 | |||
| Period Momentum Indicator | 0.94 | |||
| Relative Strength Index | 60.56 |
DaVita HealthCare Corporate Filings
F4 | 19th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 13th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 24th of September 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
| 14th of June 2024 Other Reports | ViewVerify |
DaVita Stock media impact
Far too much social signal, news, headlines, and media speculation about DaVita HealthCare that are available to investors today. That information is available publicly through DaVita media outlets and privately through word of mouth or via DaVita internal channels. However, regardless of the origin, that massive amount of DaVita data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of DaVita HealthCare news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of DaVita HealthCare relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to DaVita HealthCare's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive DaVita HealthCare alpha.
DaVita HealthCare Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards DaVita HealthCare can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
DaVita HealthCare Historical Investor Sentiment
Investor biases related to DaVita HealthCare's public news can be used to forecast risks associated with an investment in DaVita. The trend in average sentiment can be used to explain how an investor holding DaVita can time the market purely based on public headlines and social activities around DaVita HealthCare Partners. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
DaVita HealthCare's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for DaVita HealthCare and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average DaVita HealthCare news discussions. The higher the estimate score, the more favorable the investor's outlook on DaVita HealthCare.
DaVita HealthCare Maximum Pain Price Across May 16th 2025 Option Contracts
DaVita HealthCare's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of DaVita HealthCare close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of DaVita HealthCare's options.
DaVita HealthCare Corporate Directors
| Paul Diaz | Independent Director | Profile | |
| John Nehra | Independent Director | Profile | |
| Phyllis Yale | Independent Director | Profile | |
| Pascal Desroches | Independent Director | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DaVita HealthCare. If investors know DaVita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DaVita HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.909 | Earnings Share 10.74 | Revenue Per Share | Quarterly Revenue Growth 0.047 | Return On Assets |
The market value of DaVita HealthCare is measured differently than its book value, which is the value of DaVita that is recorded on the company's balance sheet. Investors also form their own opinion of DaVita HealthCare's value that differs from its market value or its book value, called intrinsic value, which is DaVita HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DaVita HealthCare's market value can be influenced by many factors that don't directly affect DaVita HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between DaVita HealthCare's value and its price, as these two are different measures arrived at by various means. Investors typically determine if DaVita HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DaVita HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.